Skip to main content

Advertisement

Table 2 Nucleotide diversity and divergence rates in the env gene and C2V3C3 region

From: Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

Patient Sampling year Age (years) ωa Nucleotide diversityb(SD) Evolutionary ratec(95% HPD)
env C2V3C3 env C2-V3-C3 env C2V3C3
Child 1 1998 0.11 0.96 1.52 0.013 (0.0061) 0.014 (0.0063) 0.0141 (0.0075, 0.0211) 0.0142 (0.0082, 0.0208)
2000 2 0.88 5.78 0.027 (0.0047) 0.015 (0.0074)
2003 5 0.65 0.50 0.027 (0.0057) 0.031 (0.0118)
Child 2 1992 0.07 1.15 0.38 0.007 (0.0022) 0.003 (0.0026) 0.0073 (0.0036, 0.0115) 0.0105 (0.0053, 0.0174)
1997 5 0.99 2.60 0.008 (0.0025) 0.005 (0.0026)
2001 9 0.66 0.62 0.035 (0.0122) 0.055 (0.0157)
  1. aRatio of nonsynonymous to synonymous substitution rates; bWithin-patient genetic distances and standard deviation (SD) as determined by averaging pairwise tree distances over all the sequences obtained for each patient at each time point; cNucleotide substitutions per site per year (HPD, highest posterior density).